Sensus Healthcare Statistics

Total Valuation

FRA:5TX has a market cap or net worth of EUR 55.06 million. The enterprise value is 34.50 million.

Market Cap	55.06M
Enterprise Value	34.50M

Important Dates

The next estimated earnings date is Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	16.43M
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	17.48%
Owned by Institutions (%)	28.05%
Float	13.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.81
PB Ratio	1.26
P/TBV Ratio	1.26
P/FCF Ratio	29.81
P/OCF Ratio	33.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-13.47
EV / Sales	1.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	18.68

Financial Position

The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.01.

Current Ratio	7.38
Quick Ratio	4.97
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	0.25
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -5.71% and return on invested capital (ROIC) is -6.38%.

Return on Equity (ROE)	-5.71%
Return on Assets (ROA)	-5.75%
Return on Invested Capital (ROIC)	-6.38%
Return on Capital Employed (ROCE)	-10.55%
Revenue Per Employee	562,029
Profits Per Employee	-47,445
Employee Count	54
Asset Turnover	0.60
Inventory Turnover	1.32

Taxes

Income Tax	-1.42M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-58.27%
50-Day Moving Average	3.09
200-Day Moving Average	3.61
Relative Strength Index (RSI)	51.45
Average Volume (20 Days)	6

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.40

Income Statement

In the last 12 months, FRA:5TX had revenue of EUR 30.35 million and -2.56 million in losses. Loss per share was -0.16.

Revenue	30.35M
Gross Profit	14.55M
Operating Income	-4.63M
Pretax Income	-3.98M
Net Income	-2.56M
EBITDA	-4.32M
EBIT	-4.63M
Loss Per Share	-0.16

Full Income Statement

Balance Sheet

The company has 20.84 million in cash and 455,128 in debt, giving a net cash position of 20.39 million.

Cash & Cash Equivalents	20.84M
Total Debt	455,128
Net Cash	20.39M
Net Cash Per Share	n/a
Equity (Book Value)	43.63M
Book Value Per Share	2.65
Working Capital	36.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.63 million and capital expenditures 220,746, giving a free cash flow of 1.85 million.

Operating Cash Flow	1.63M
Capital Expenditures	220,746
Free Cash Flow	1.85M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 47.95%, with operating and profit margins of -15.26% and -8.44%.

Gross Margin	47.95%
Operating Margin	-15.26%
Pretax Margin	-13.13%
Profit Margin	-8.44%
EBITDA Margin	-14.22%
EBIT Margin	-15.26%
FCF Margin	6.09%

Dividends & Yields

FRA:5TX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	-4.65%
FCF Yield	3.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:5TX has an Altman Z-Score of 8.96 and a Piotroski F-Score of 2.

Altman Z-Score	8.96
Piotroski F-Score	2